List of works - Francisca Ferrer-Marín

An atypical IgM class platelet cold agglutinin induces GPVI-dependent aggregation of human platelets.

scientific article

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.

scientific article published on 12 May 2016

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

scientific article published on 12 December 2011

Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.

scientific article

Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia.

scientific article published on 17 April 2017

Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide.

scientific article published on 26 January 2013

Correction of anaemia on dialysis: did we forget physiology?

scientific article published on 01 March 2011

Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia

scientific article published on 03 August 2020

Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes

scientific article

Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice

scientific article

Effects of in vitro adult platelet transfusions on neonatal hemostasis

scientific article

Evaluation of Novel Platelet Polymorphisms in Stroke. Dichotomic Effect of rs5443 in GNB3.

scientific article

Evaluation of two-step haemoglobin screening with HemoCue for blood donor qualification in mobile collection sites.

scientific article published on 11 June 2014

Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera.

scientific article published on 21 December 2015

Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response

scientific article published on 8 October 2016

Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia

scientific article

Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation.

scientific article

Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?

scientific article

Indirect and non-medical economic burden, quality-of-life, and disabilities of the myelofibrosis disease in Spain.

scientific article published on 9 April 2014

Leukaemic transformation in patients with haematological disease receiving tumour necrosis factor inhibitors

scientific article published in June 2012

Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing.

scientific article published on 8 September 2013

Long-term results of prednisone treatment for the anemia of myelofibrosis.

scientific article

Neonatal thrombocytopenia and megakaryocytopoiesis

scientific article

Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction

scientific article published on 27 May 2016

Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia

scientific article published on 14 February 2015

Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis

scientific article published on 23 December 2016

Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera.

scientific article

Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea

scientific article published on 29 September 2016

Successful ovarian stimulation and pregnancy in an infertile woman with chronic myeloid leukemia

scientific article published on 06 August 2020

Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies

scientific article

The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis

scientific article published on 31 January 2014

The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms.

scientific article published on 9 December 2014

[Concurrent lymphoid and Philadelphia chromosome-negative myeloproliferative neoplasms].

scientific article

List of works by Francisca Ferrer-Marín

An atypical IgM class platelet cold agglutinin induces GPVI-dependent aggregation of human platelets.

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.

Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia.

Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide.

Correction of anaemia on dialysis: did we forget physiology?

Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia

Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes

Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice

Effects of in vitro adult platelet transfusions on neonatal hemostasis

Evaluation of Novel Platelet Polymorphisms in Stroke. Dichotomic Effect of rs5443 in GNB3.

Evaluation of two-step haemoglobin screening with HemoCue for blood donor qualification in mobile collection sites.

Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera.

Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response

Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia

Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation.

Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?

Indirect and non-medical economic burden, quality-of-life, and disabilities of the myelofibrosis disease in Spain.

Leukaemic transformation in patients with haematological disease receiving tumour necrosis factor inhibitors

Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing.

Long-term results of prednisone treatment for the anemia of myelofibrosis.

Neonatal thrombocytopenia and megakaryocytopoiesis

Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction

Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia

Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis

Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera.

Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea

Successful ovarian stimulation and pregnancy in an infertile woman with chronic myeloid leukemia

Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies

The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis

The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms.

[Concurrent lymphoid and Philadelphia chromosome-negative myeloproliferative neoplasms].